• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 3. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 4. Aluminium electrodeposition under ambient conditions
  Andrew P. Abbott,Robert C. Harris,Karl S. Ryder,I-Wen Sun Phys. Chem. Chem. Phys., 2014,16, 14675-14681
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzotriazoles

Recent Advances in the Study of Methanone,1H-benzotriazol-1-yl-2-thienyl- (CAS: 301164-69-2)

Methanone,1H-benzotriazol-1-yl-2-thienyl- (CAS: 301164-69-2) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a versatile intermediate in organic synthesis and its biological activities, particularly in the context of drug discovery and development. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, mechanism of action, and potential applications in medicine.

One of the key areas of interest in recent research is the compound's role as a coupling reagent in peptide synthesis. Studies have demonstrated that Methanone,1H-benzotriazol-1-yl-2-thienyl- exhibits high efficiency in facilitating amide bond formation, a critical step in the synthesis of peptides and peptidomimetics. Its ability to activate carboxylic acids and promote coupling reactions under mild conditions makes it a valuable tool for chemists working on complex molecular architectures. Furthermore, its stability and compatibility with a wide range of functional groups have been highlighted in several synthetic protocols.

In addition to its synthetic applications, recent investigations have explored the biological activities of Methanone,1H-benzotriazol-1-yl-2-thienyl-. Preliminary studies suggest that derivatives of this compound may exhibit antimicrobial and anti-inflammatory properties, making them potential candidates for the development of new therapeutic agents. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that certain analogs of this compound showed promising activity against resistant bacterial strains, possibly through inhibition of key enzymatic pathways. These findings open new avenues for the design of novel antibiotics.

Another noteworthy aspect of Methanone,1H-benzotriazol-1-yl-2-thienyl- is its potential role in targeted drug delivery systems. Researchers have investigated its use as a linker molecule in prodrug strategies, where it can be employed to conjugate active pharmaceutical ingredients (APIs) with targeting moieties. This approach aims to enhance drug specificity and reduce off-target effects, thereby improving therapeutic outcomes. Recent in vitro and in vivo studies have provided encouraging results, demonstrating the compound's utility in constructing stable and bioresponsive drug conjugates.

Despite these advancements, challenges remain in the optimization of Methanone,1H-benzotriazol-1-yl-2-thienyl- for clinical applications. Issues such as scalability of synthesis, pharmacokinetic properties, and potential toxicity need to be addressed through further research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to fully unlock the potential of this compound. Future studies should focus on elucidating its mechanism of action at the molecular level and exploring its applicability in diverse therapeutic areas.

In conclusion, Methanone,1H-benzotriazol-1-yl-2-thienyl- (CAS: 301164-69-2) represents a promising scaffold in chemical biology and pharmaceutical research. Its dual role as a synthetic reagent and a biologically active molecule underscores its versatility and potential impact on drug discovery. Continued research efforts are expected to yield deeper insights into its applications, paving the way for innovative therapeutic solutions. This brief serves as a snapshot of the current state of knowledge and highlights the exciting possibilities that lie ahead for this compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)